{"id":202166,"name":"ACHAOGEN","slug":"achaogen","state":"CA","country":"United States of America","description":"","totalSpending":170000,"filings":4,"yearlySpending":[{"year":2018,"income":170000}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"HCR","display":"Health Issues"}],"firms":["ACHAOGEN"],"lobbyists":["STEPHANIE DYSON"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","White House Office"],"sampleDescriptions":["REVAMP- antibiotic pull incentive \nDISARM- antibiotic reimbursement \nHospital reimbursement ( NTAP and DRG)\nBARDA funding \nPAHPA reauthorization as it pertains to antibiotics","Public Health and Bio threat issues as it pertains to antibiotics \nHospital reimbursement for antibiotics ( NTAP and DRG)\nBARDA funding and other private/public funding issues","REVAMP- antibiotic pull incentive \nDISARM- antibiotic reimbursement \nHospital reimbursement ( NTAP and DRG)\nBARDA funding \nPAHPA reauthorization as it pertains to antibiotics","Public Health and Bio threat issues as it pertains to antibiotics \nHospital reimbursement for antibiotics ( NTAP and DRG)\nBARDA funding and other private/public funding issues","Public Health and Bio threat issues as it pertains to antibiotics \nHospital reimbursement for antibiotics ( NTAP and DRG)\nBARDA funding and other private/public funding issues"]}